Thu, November 17, 2022

Salveen Richter Upgraded (AGIO) to Hold and Increased Target to $32 on, Nov 17th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-32-on-nov-17th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Salveen Richter of Goldman Sachs, Upgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Increased Target from $17 to $32 on, Nov 17th, 2022.

Salveen has made no other calls on AGIO in the last 4 months.



There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with Salveen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Salveen


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $37 on, Friday, August 5th, 2022